Sfoglia per RIVISTA
FRONTIERS IN ENDOCRINOLOGY
Collezione ASL VCO
Items : 1
Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes in Frontiers in Endocrinology
2025
ASL VCO
Colletta A; Cooper KM; Placentino G; Devuni D; Colletta C;